Medipal Holdings ADR (MAHLY) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	952.40B	1.01T	905.69B	989.50B
Cost of goods sold	886.80B	945.36B	843.72B	923.77B
Cost of revenue	886.80B	945.36B	843.72B	923.77B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	51.21B	47.23B	48.52B	48.83B
Operating expense	54.58B	50.64B	51.97B	52.35B
Total operating expenses	941.38B	996.00B	895.69B	976.12B
Operating income	11.02B	18.10B	9.99B	13.39B
Other non operating income	2.79B	3.16B	2.14B	2.77B
EBT including unusual items	21.14B	26.77B	15.27B	23.70B
EBT excluding unusual items	16.04B	26.82B	14.18B	17.92B
Income tax expense	6.27B	8.45B	7.93B	7.76B
Effective tax rate	29.66%	31.56%	51.95%	32.73%
Other operating expenses	-	-	-	-
Net income	12.50B	15.32B	5.12B	13.65B
Net profit margin	1.31%	1.51%	0.57%	1.38%
Earnings per share	-	-	-	-
Interest and investment income	862.00M	4.57B	1.36B	871.00M
Interest expense	-3.00M	-3.00M	-4.00M	-3.00M
Net interest expenses	859.00M	4.56B	1.35B	868.00M
Depreciation and amortization charges	3.37B	3.41B	3.45B	3.51B
EBITDA	15.63B	21.51B	17.04B	20.44B
Gain or loss from assets sale	-	-	-	-

Ask anything